Emtricitabine | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Emtricitabine
US Exclusivities

With Fermion, start the journey of your innovative API.

Contact Supplier

Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

Contact Supplier

dmfs-not-supported-m-2025-06-30

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

veranova-m-2025-06-30

Contact Supplier

jdmfs-not-supported-m-2025-06-30

Emtricitabine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 16 USDMF, 2 JDMF, 15 EU WC, 5 KDMF, 20 NDC API, 17 Listed Suppliers, $ API Reference Price

39 API Suppliers
16 USDMF
2 JDMF
15 EU WC
5 KDMF
20 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

30 Drugs in Development

30 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

174 FDF Dossiers, 56 FDA Orange Book, 32 Europe, 24 Canada, 50 South Africa, 12 Listed Dossiers

174 FDF Dossiers
56 FDA Orange Book
32 Europe
24 Canada
50 South Africa
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
TABLET;ORAL - 120MG;EQ 15MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE
CAPSULE;ORAL - 200MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 10 DKSH, 6 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 31 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 32 Controlled & Modified Release, 24 Thickeners and Stabilizers, 22 Granulation, 20 Direct Compression, 19 Disintegrants & Superdisintegrants, 17 Solubilizers, 17 Topical, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 11 Taste Masking, 11 Film Formers & Plasticizers, 9 Empty Capsules, 9 Parenteral, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

64 Fillers, Diluents & Binders
51 Coating Systems & Additives
32 Controlled & Modified Release
24 Thickeners and Stabilizers
22 Granulation
20 Direct Compression
19 Disintegrants & Superdisintegrants
17 Solubilizers
17 Topical
15 Lubricants & Glidants
14 Co-Processed Excipients
11 Taste Masking
11 Film Formers & Plasticizers
9 Empty Capsules
9 Parenteral
7 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 API Stability Enhancers
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
3 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 192 News #PharmaBuzz

3 Data Compilation #PharmaFlow
2 Stock Recap #PipelineProspector
192 News #PharmaBuzz

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 29 Regulatory FDF Prices, 57 Annual Reports

23 US Medicaid Prescriptions
29 Regulatory FDF Prices
57 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

8 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

96 US Patents, 9 US Exclusivities, 2 Health Canada Patents

96 US Patents
9 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 4 Others

4 USP
4 Others

$ API Ref.Price (USD/KG) : 314 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

9 All

01 8GILEAD SCIENCES INC

02 1MYLAN

filter Product Reset all filters

9 All

01 7BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

02 1EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

03 1EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

filter Exclusivity Expiration Date Reset all filters

9 All

01 12025-11-23

02 12026-06-18

03 22027-02-23

04 12027-04-24

05 12028-10-07

06 12029-01-07

07 22031-02-23

filter Exclusivity Code Reset all filters

9 All

01 2I-942

02 1M-305

03 1ODE-256

04 1ODE-378

05 1ODE-457

06 2ODE-468

07 1PC

Product Main Page

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-256

Exclusivity Expiration Date

2026-06-18

Application Number

210251

Product Number

1

Exclusivity Details

01

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-256

Exclusivity Expiration Date : 2026-06-18

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-305

Exclusivity Expiration Date

2027-04-24

Application Number

210251

Product Number

1

Exclusivity Details

02

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : M-305

Exclusivity Expiration Date : 2027-04-24

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-942

Exclusivity Expiration Date

2027-02-23

Application Number

210251

Product Number

1

Exclusivity Details

03

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : I-942

Exclusivity Expiration Date : 2027-02-23

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-457

Exclusivity Expiration Date

2029-01-07

Application Number

208215

Product Number

2

Exclusivity Details

04

GILEAD SCIENCES INC

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-457

Exclusivity Expiration Date : 2029-01-07

Application Number : 208215

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

MYLAN

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PC

Exclusivity Expiration Date

2025-11-23

Application Number

208452

Product Number

1

Exclusivity Details

05

MYLAN

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

Pharmex

Not Confirmed

MYLAN

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

Exclusivity Code : PC

Exclusivity Expiration Date : 2025-11-23

Application Number : 208452

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-468

Exclusivity Expiration Date

2031-02-23

Application Number

210251

Product Number

2

Exclusivity Details

06

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-468

Exclusivity Expiration Date : 2031-02-23

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-378

Exclusivity Expiration Date

2028-10-07

Application Number

210251

Product Number

2

Exclusivity Details

07

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-378

Exclusivity Expiration Date : 2028-10-07

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-942

Exclusivity Expiration Date

2027-02-23

Application Number

210251

Product Number

2

Exclusivity Details

08

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : I-942

Exclusivity Expiration Date : 2027-02-23

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-468

Exclusivity Expiration Date

2031-02-23

Application Number

210251

Product Number

1

Exclusivity Details

09

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Pharmex

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Pharmex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-468

Exclusivity Expiration Date : 2031-02-23

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!